Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

NCT01704690 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped The enrollment of the study is much slower than expected.

Conditions

Esophageal Cancer

Interventions

DRUG: S-1 and Paclitaxel
DRUG: Paclitaxel and Cisplatin
DRUG: 5-FU and Cisplatin

Sponsor

Peking University